Evidence map›Paper›PMID 39675348›Full record

GuidelineHormone research in paediatrics2024

ISPAD Clinical Practice Consensus Guidelines 2024: Type 2 Diabetes in Children and Adolescents.

Amy S Shah, Margarita Barrientos-Pérez, Nancy Chang, Jun-Fen Fu, Tamara S Hannon, Megan Kelsey, Alexia S Peña, Orit Pinhas-Hamiel, Tatsuhiko Urakami, Brandy Wicklow and 2 more

Abstract readPractice GuidelineReview
PubMed Full text at PMC Publisher
In one paragraph

Guideline in Hormone research in paediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Guideline
  7. Article
  8. Review
  9. Article
  10. Article
  11. Prediabetes in children and adolescents: what do we need to know?Annals of pediatric endocrinology & metabolism · 2026
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Pros and Cons of Early Treatment with GLP-1 Receptor Agonist and SGLT-2 Inhibitors for Youth with Type 2 Diabetes: A Narrative Review.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Amy S ShahDivision of Endocrinology, Cincinnati Children's Hospital Medical Center and the University of Cincinnati, Cincinnati, Ohio, USA.
Margarita Barrientos-PérezDivision of Clinical Research, Hospital Ángeles Puebla, Puebla, Mexico.
Nancy ChangCenter for Endocrinology, Diabetes and Metabolism, Children's Hospital Los Angeles, Los Angeles, California, USA.
Jun-Fen FuDepartment of Endocrinology, Children's Hospital Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
Tamara S HannonDivision of Endocrinology, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Megan KelseySection of Endocrinology, Department of Pediatrics, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA.
Alexia S PeñaRobinson Research Institute and Women's and Children's Hospital, The University of Adelaide, North Adelaide, South Australia, Australia.
Orit Pinhas-HamielEdmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel.
Tatsuhiko UrakamiNihon University School of Medicine, Tokyo, Japan.
Brandy WicklowDivision of Endocrinology, Children's Hospital Research Institute of Manitoba, Winnipeg Children's Hospital and University of Manitoba, Winnipeg, Manitoba, Canada.
Jencia WongDepartment of Endocrinology, Royal Prince Alfred Hospital and Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
Farid H MahmudDivision of Endocrinology, Hospital for Sick Children, Sick Kids Research Institute, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Youth-onset type 2 diabetes (T2D) results from genetic, environmental, and metabolic causes that differ among individuals and populations. This chapter builds on the 2022 ISPAD guidelines and summarizes recent advances in the management of T2D in children and adolescents. Updates include diagnostic algorithm for youth with new onset T2D, algorithms and tables for treatment, management, and assessment of comorbidities and complications and recommendations on recently approved pharmacologic therapies for the treatment of youth-onset T2D and management strategies. Youth-onset type 2 diabetes (T2D) results from genetic, environmental, and metabolic causes that differ among individuals and populations. This chapter builds on the 2022 ISPAD guidelines and summarizes recent advances in the management of T2D in children and adolescents. Updates include diagnostic algorithm for youth with new onset T2D, algorithms and tables for treatment, management, and assessment of comorbidities and complications and recommendations on recently approved pharmacologic therapies for the treatment of youth-onset T2D and management strategies.

Indexed as

Diabetes Mellitus, Type 2EndocrinologyAdolescentAlgorithmsChildFemaleHumansMaleAdolescentsChildrenComplicationsManagementType 2 diabetes

Identifiers

PMID39675348
PMCPMC11854986

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.